Starting today, people with Parkinson's disease will have a new treatment option, thanks to U.S. Food and Drug Administration approval of groundbreaking new technology.
The FDA approved adaptive deep brain stimulation (DBS) technology (BrainSense adaptive DBS and BrainSense electrode ...
After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...
A form of Parkinson's disease caused by mutations in a gene known as PINK1 has long been labelled rare. But our research shows it's anything but ...
New research shows people in specific Polynesian communities have a much higher rate of a form of Parkinson’s disease ...
There is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...
The closed-loop system dynamically self-adjusts DBS therapy to individual brain activity in real time, providing personalized ...
Medtronic has received approval from the FDA for BrainSense, its aDBS therapy for patients living with Parkinson’s disease.
The company's adaptive deep brain stimulation technology for Parkinson's disease therapy is expected to be available nationwide in the next few months.
New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever ...
Medtronic said the Food and Drug Administration approved a brain stimulation system for people afflicted with Parkinson's disease.